Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to...
Leadership
David-Alexandre C. Gros M.D., Ph.D.
CEO & Non Independent Director
Steven N. Perrin Ph.D.
President, Chief Scientific Officer & Non Independent Director
Paul Sean Little
Chief Financial Officer
John Herberger
Vice President of Technical Operations
Bryan E. Smith J.D.
General Counsel, Corporate Secretary & Chief Compliance Officer
